Involvement of CD40-CD40L signaling in postischemic lung injury

Timothy M Moore1, W Bradley Shirah, Pavel L Khimenko

  • 1Department of Physiology, University of Alabama College of Medicine, Mobile, Alabama 36688-0002, USA.

Insights

Ischemia-reperfusion injury in rat lungs involves lymphocytes and CD40-CD40L signaling, increasing microvascular permeability. Blocking this pathway or using IL-10 reduces lung injury.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Vascular Biology

Background:

  • Ischemia-reperfusion (I/R) injury is a significant cause of lung damage.
  • Lymphocyte retention and increased microvascular permeability characterize post-I/R lung injury.

Purpose of the Study:

  • To investigate the role of CD40-CD40L interactions and IL-10 in I/R-induced lung injury.
  • To determine the impact of these pathways on microvascular permeability and inflammatory responses.

Main Methods:

  • Isolated rat lung model subjected to I/R.
  • Quantitative measurement of microvascular filtration coefficient (K(f,c)).
  • Immunoneutralization of CD40/CD40L and manipulation of IL-10 levels.

Main Results:

  • I/R increased K(f,c), indicating enhanced permeability.
  • Blocking CD40-CD40L signaling significantly reduced post-ischemic K(f,c) and MIP-2 production.
  • Activated lymphocytes exacerbated K(f,c), an effect blocked by anti-CD40.
  • IL-10 antagonism worsened I/R injury, while exogenous IL-10 provided protection.

Conclusions:

  • Lymphocyte involvement in lung I/R injury is mediated by CD40-CD40L signaling.
  • Local IL-10 production influences I/R-induced microvascular damage.
  • Targeting CD40-CD40L and modulating IL-10 represent potential therapeutic strategies for lung I/R injury.